ClinicalTrials.govpublic full text
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
acute myeloid leukemia, graft versus host disease, myelodysplastic syndrome, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 981826
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.